Stockscreener 앱 받기
162.31
3.50%
-5.88
시간 외 거래:
157.90
-4.41
-2.72%
전일 마감가:
$168.19
열려 있는:
$167.5
하루 거래량:
1.54M
Relative Volume:
1.21
시가총액:
$19.93B
수익:
$1.53B
순이익/손실:
$-214.69M
주가수익비율:
-92.22
EPS:
-1.76
순현금흐름:
$-43.68M
1주 성능:
-6.39%
1개월 성능:
-3.08%
6개월 성능:
+33.14%
1년 성능:
+132.67%
1일 변동 폭
$159.20
$168.88
1주일 범위
$159.20
$180.41
52주 변동 폭
$69.74
$183.00
Natera Inc Stock (NTRA) Company Profile
명칭
Natera Inc
전화
650-249-9090
주소
13011 MCCALLEN PASS, AUSTIN, CA
NTRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
162.31 | 19.93B | 1.53B | -214.69M | -43.68M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
532.55 | 203.70B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.23 | 151.18B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
135.37 | 38.62B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
452.77 | 37.07B | 3.90B | 887.87M | 808.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
191.04 | 33.64B | 15.41B | 1.37B | 2.11B | 7.50 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-08 | 재개 | Craig Hallum | Buy |
| 2024-02-20 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 재확인 | BTIG Research | Buy |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-11-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-01-18 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 개시 | Stephens | Overweight |
| 2022-03-08 | 개시 | Goldman | Buy |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-09-28 | 개시 | Morgan Stanley | Overweight |
| 2020-09-17 | 개시 | SVB Leerink | Outperform |
| 2020-06-10 | 재개 | Piper Sandler | Overweight |
| 2020-05-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 개시 | JP Morgan | Neutral |
| 2018-07-05 | 재확인 | Piper Jaffray | Overweight |
| 2017-08-07 | 재확인 | Morgan Stanley | Overweight |
| 2016-11-10 | 재확인 | The Benchmark Company | Buy |
| 2016-05-23 | 재확인 | The Benchmark Company | Buy |
| 2016-05-11 | 재확인 | The Benchmark Company | Buy |
| 2016-04-19 | 개시 | The Benchmark Company | Buy |
| 2015-09-28 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2015-08-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 개시 | Robert W. Baird | Outperform |
| 2015-07-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 개시 | Piper Jaffray | Overweight |
| 2015-07-27 | 개시 | Wedbush | Neutral |
모두보기
Natera Inc 주식(NTRA)의 최신 뉴스
Guardant Health sues rival Natera over cancer-testing trade secrets - Reuters
Guardant Health stock falls after Natera lawsuit (GH:NASDAQ) - Seeking Alpha
Natera Stole Guardant Cancer Test Trade Secrets, Suit Says - Bloomberg Law
Ieq Capital LLC Purchases 51,637 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Rhumbline Advisers Sells 1,620 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Vontobel Holding Ltd. Lowers Stake in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Natera (NTRA) to Release Earnings on Wednesday - MarketBeat
Is Gilead Sciences (GILD) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Alberta Investment Management Corp Sells 5,011,459 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Shares Bought by Van ECK Associates Corp - MarketBeat
Natera (NTRA) Surged on Blowout Quarterly Results - Insider Monkey
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Principal Financial Group Inc. - MarketBeat
Chevy Chase Trust Holdings LLC Boosts Stock Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Banque Pictet & Cie SA Decreases Holdings in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025 - Business Wire
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Kornitzer Capital Management Inc. KS - MarketBeat
Natera (NTRA) Recently Broke Out Above the 20-Day Moving Average - MSN
Quent Capital LLC Sells 3,008 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Natera CEO Steven Chapman sells $12.96m in stock - MSN
Natera CFO Michael Burkes sells $4.28m in stock - MSN
Natera's chief legal officer sells $3.64 million in stock - MSN
11,294 Shares in Natera, Inc. (NASDAQ:NTRA) Bought by Guided Capital Wealth Management LLC - MarketBeat
Allspring Global Investments Holdings LLC Sells 115,810 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Stock Holdings Lowered by abrdn plc - MarketBeat
Empowered Funds LLC Decreases Stock Holdings in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera stock holds at $175 target, Raymond James sees progress - MSN
Sumitomo Mitsui Trust Group Inc. Purchases 69,455 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Canaccord maintains $180 target on Natera stock post-NCCN update - MSN
Mirae Asset Global Investments Co. Ltd. Sells 42,869 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Lecap Asset Management Ltd. Sells 3,150 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
John Fesko Sells 663 Shares of Natera, Inc. (NASDAQ:NTRA) Stock - MarketBeat
Trade Tracker: Amy Raskin trims Vertex, Natera & Kadant, buys CareDx and Impinj - CNBC
October 17th Options Now Available For Natera (NTRA) - Nasdaq
Natera, Inc. Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma - Marketscreener.com
Major Clinical Guidelines Update: Natera's Cancer Test Shows 20x Better Risk Detection - StockTitan
NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma - Yahoo Finance
Natera Inc (NTRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.06%
1.57%
자본화:
|
볼륨(24시간):